MONUDIN
Dead / Cancelled — Cancelled — Section 8 (as of 11 Oct 2013)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78262176
- Registration number
- 3214651
- Mark type
- Word mark
- Filed
- 13 Jun 2003
- Published for opposition
- 05 Sept 2006
- Registered
- 06 Mar 2007
- Attorney of record
- Christopher J. Schulte, Esq.
Goods and services
- Class 001 — Chemicals: Chemical and biochemical products for use in gene delivery technology, namely, enzymes, proteins, growth factors and chemicals for in-vitro use in laboratories and for analysis in gene delivery technology; micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic acid variations thereof, all for in-vivo use in gene delivery technology
- Class 005 — Pharmaceuticals: Gene therapy and prophylaxis products, namely gene transfer, regulation, modulation and delivery products for the treatment of motor neurone disease, blood disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, vascular disorders, disorders arising from improper vascularization and single gene disorders; pharmaceutical substances and preparations namely, vaccines, genetically engineered proteins enzymes and enzyme preparations for medical diagnostic use; retroviral vector and retroviral vector manufacturing preparations for use in gene delivery; pharmaceutical and biochemical preparations for the treatment of single gene disorders
- Class 010 — Medical apparatus: Instruments and apparatus for the administration of gene and antibody-based therapy and prophylaxis preparations and substances, namely, pre-filled vials, syringes and injectors for medical purposes, all for the treatment of single gene disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, blood disorders, vascular disorders and disorders arising from inappropriate vascularization
- Class 042 — Scientific and technological services: Scientific and medical research and development; genetic engineering services, biotechnology services, namely, research and development of new technology for others in the field of biotechnology; licensing of intellectual property; product development consultation relating to gene therapy products; consultation services in the fields of medical and scientific research in the field of professional gene therapy
Owner
- Oxford BioMedica plc, Oxford, GB
- Oxford BioMedica plc, Oxford, GB
- Oxford BioMedica plc, Oxford, GB
Prosecution history
- 11 Oct 2013 — CANCELLED SEC. 8 (6-YR)
- 06 Mar 2007 — REGISTERED-PRINCIPAL REGISTER
- 23 Jan 2007 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 23 Jan 2007 — NOTICE OF ALLOWANCE CANCELLED
- 26 Dec 2006 — PAPER RECEIVED
- 28 Nov 2006 — NOA MAILED - SOU REQUIRED FROM APPLICANT
- 05 Sept 2006 — PUBLISHED FOR OPPOSITION
- 16 Aug 2006 — NOTICE OF PUBLICATION
- 11 Jul 2006 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 07 Jul 2006 — ASSIGNED TO LIE
- 03 Jul 2006 — EXAMINERS AMENDMENT MAILED
- 03 Jul 2006 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Jul 2006 — EXAMINER'S AMENDMENT ENTERED
- 03 Jul 2006 — EXAMINERS AMENDMENT -WRITTEN
- 07 Jun 2006 — TEAS/EMAIL CORRESPONDENCE ENTERED